Study Notes on Nuclear Medicine

Introduction to Nuclear Medicine

Medical Physics Program

• University of Thessaly, Greece

Learning Objectives

1. What is Nuclear Medicine?

   • Definition: Nuclear Medicine employs small amounts of radioactive materials, called radiopharmaceuticals, for diagnosing and treating diseases. This branch of medicine exploits the ability of radiopharmaceuticals to visualize organ and tissue function.
   • Primary Uses: Primarily utilized for diagnosis and treatment in medical research.
   • Role of Radiopharmaceuticals: Essential for detecting and visualizing the function of organs and tissues.

2. Historical Background

   • Key Events and Figures: Identify significant contributors to Nuclear Medicine, including discoveries related to radioactivity and its applications.
   • Technological Evolution: Describe the development from the initial discovery of radioactivity to contemporary imaging methods.

3. Information from Nuclear Medicine Examinations

   • Provide functional insights into organ physiology and pathology.
   • Compare how Nuclear Medicine contrasts with other imaging techniques (e.g., X-ray, CT).

4. Mechanism of Gamma Camera

   • Explain how a gamma camera functions and the process of detecting radioactive emissions.
   • Describe the conversion of data into images for diagnostic purposes.

5. Working of PET Scan

   • Explain how PET scans operate, emphasizing the principle of positron emission.
   • Recognize the application of PET scans in disease diagnosis and monitoring, particularly in cancer.

6. Clinical Applications

   • Discuss the main clinical uses of Nuclear Medicine for both diagnosis and treatment.
   • Evaluate its contributions toward health improvement and medical research.

Definition of Nuclear Medicine

• Nuclear medicine is defined as a branch of medicine that utilizes small amounts of radioactive materials known as radiopharmaceuticals to diagnose, treat, and conduct medical research.
• It relies on the capacity of these radiopharmaceuticals to assess and visualize the function of various organs and tissues within the human body.

Characteristics of Nuclear Medicine

Diagnosis

• Imaging Function: Facilitates imaging of internal organ functions (e.g., heart, kidneys, thyroid).
• Information Detail: Reveals insights into normal or pathological organ functions, often before structural changes become evident.

Therapy

• Utilized in treating conditions such as thyroid cancer and bone metastases, by administering radioactive materials designed to destroy affected cells.

Technology

• Incorporates specialized devices like gamma cameras and PET scans to document emitted radiation and translate it into image form.

Comparison with Other Imaging Modalities

• Unlike other imaging specialties (e.g., radiology), Nuclear Medicine emphasizes the visualization of organ functionality over mere morphology.
• Provides diagnostic information that can potentially eliminate the need for invasive surgical procedures or complex diagnostic studies.
• Ability to identify abnormalities at early, often asymptomatic stages, facilitating improved prognosis through early diagnosis.

A Detailed Look at Radiation Sources

Functional Information vs. Anatomical Information

• Nuclear Medicine:

  • Radiation Source: Internal (from radiopharmaceuticals).
  • Information Provided: Functional information about organ physiology.

• X-ray, CT, etc.:

  • Radiation Source: External (from an X-ray tube).
  • Information Provided: Anatomical/morphological information.

Historical Overview

• 1896: Henri Becquerel discovered radioactivity while studying uranium.
• 1900-1908: Marie and Pierre Curie conducted extensive research on radium and polonium, laying the groundwork for radiological studies.
• 1897: Ernest Rutherford identified alpha and beta rays as parts of radioactive emissions.

Definition of Radioactivity

• Radioactivity: Defined by Rutherford and Soddy as “the property of certain nuclei to spontaneously transition to a lower energy state, emitting particles or electromagnetic radiation.”
  • Decay Mechanism: Involves a decaying nucleus labeled as the parent, which transitions into a daughter nucleus.

Key Innovators in Nuclear Medicine

Hal Anger

• 1950s: Developed the first gamma camera, revolutionizing Nuclear Medicine. He also created a gamma counter for laboratory settings dealing with small radionuclide amounts (e.g., Radionuclide Immunoassay).

Ernest O. Lawrence

• 1929: Created the cyclotron, enhancing the availability of radioisotopes essential for Nuclear Medicine and Radiobiology.

Basic Elements of Nuclear Physics

Nuclides

• Definition: A nuclide is defined as the nucleus of an atom characterized by a specific number of protons (Z) and neutrons (N). Example: The nucleus of oxygen-16, where Z = 8 and N = 8.
• Count of Nuclides: There are approximately 2,500 nuclides (including both natural and artificial ones).

Energy States of Nuclides

• Nuclides possess distinct energy states, transitioning from higher to lower states and emitting energy as radiation.
• A total of 279 nuclides among 83 elements are stable in nature.

Radionuclides

• Unstable Nuclides: Defined as those with the inherent ability to transition to a lower energy state, releasing energy as particles or electromagnetic radiation—a phenomenon called radioactivity.
• Decay Rate: The decay rate of a radionuclide remains constant, unaffected by physical or chemical changes.
• Isotopes: They are different forms of the same element, sharing the same atomic number Z but differing in mass number A. Isotopes can be stable or unstable; the unstable forms emit radiation as they decay to stable configurations.

Mathematical Concepts

• The decay constant (λ) is a constant property indicating the probability of a specific radionuclide decaying within one second. The number of nuclei decaying over a time interval is proportional to the total remaining undecayed nuclei:
  $rac{ ext{d}N}{ ext{d}t} = - ext{λ}N$

• To describe radioactive decay mathematically, we determine the number of undecayed nuclei (N) at time (t) using:
  $N = N_0e^{- ext{λ}t}$
  Where N0 is the number of original nuclei.

• The physical half-life (T₁/₂) denotes the period required for the number of nuclei to decrease to half its original quantity.

Radioactive Decay Mechanisms

• Parent and Daughter Nuclei: The starting nucleus in a decay process is referred to as the parent, while the result is called the daughter. This decay process stops when a stable nucleus is formed.

Types of Radioactive Decay

1. Alpha decay (α)
2. Beta-minus decay (β⁻)
3. Beta-plus decay (β⁺)
4. Gamma decay (γ)

X-rays vs. Gamma rays

X-ray Characteristics

• Discovered by: Wilhelm Roentgen in 1895.
• Nature: Comprised of electromagnetic waves (photons).
• Production: Occurs during atomic de-excitations and when charged particles experience deceleration.
• Applications: Used prominently in radiodiagnosis and radiotherapy owing to their high penetration capabilities.

Gamma Ray Characteristics

• Discovered by: Henri Becquerel in 1896.
• Nature: Also consists of electromagnetic waves (photons).
• Production: Generated during nuclear de-excitations and have vast applications in Nuclear Medicine.

Applications of Nuclear Medicine

In Vivo vs In Vitro Procedures

In Vivo Testing

• Involves patient participation in functional procedures.

In Vitro Testing

• Involves analyzing biological fluid samples (such as blood) to determine concentrations of specific compounds without irradiating the patient.

Radio-Immunoassay (RIA)

• Purpose: An extremely sensitive laboratory technique designed to measure minuscule amounts of substances, including hormones and vitamins, found in blood samples.

RIA Methodology

1. Competition of substances: Combines a known quantity of a radioactively labeled substance with the sample containing the unlabeled counterpart.
2. Antibody Binding: An antibody is introduced that binds both the labeled and unlabeled substances, initiating competition.
3. Separation: Bound material is separated from unbound materials to retain only the antibody-substance complex.
4. Radioactivity Measurement: The radioactivity of the bound portion is measured; a lower reading indicates a higher concentration of unlabeled substances.
5. Calculation: The difference in radioactivity level allows for quantification using a standard calibration curve.

RIA Example

• To measure insulin levels in a blood sample, radioactive insulin is added. A higher concentration of insulin in the sample leads to less binding of the radioactive counterpart with antibodies which correlates with activity levels measured.

Therapeutic Applications in Nuclear Medicine

General Overview

• Involves administering calculated quantities of radioisotopes tailored to the specific disease for targeting and therapeutic purposes. The choice of radiopharmaceutical is influenced by factors including:
  1. Biological behavior of the selected pharmaceutical.
  2. Physical properties of the radionuclide—in particular, ensuring the dose adequately targets the intended irradiation site.

Safety Considerations

• Given the significant volume of radioactivity utilized during treatment, strict safety measures are enforced to protect healthcare workers, patients, and the broader public.

Radiopharmaceuticals

Definition: Radiopharmaceuticals comprise radioactive isotopes combined with bioactive agents for diagnostic imaging or therapeutic application.

Objectives in Selection

• Minimize patient radiation dose while maximizing diagnostic/treatment efficacy.

Usage Examples of Radiopharmaceuticals

• Examples: Such as technetium, thallium, gallium, iodine, fluorine, and oxygen, utilized for analyzing organ function and generating images at cellular to molecular levels.
  Formula Example: Involves the combination of a radioactive component with a pharmacological compound, e.g.,
  Fluorine-18 + Glucose = Fluorodeoxyglucose (18F-FDG) used in PET imaging.

Properties of Radiopharmaceuticals

• Selection ensures:
  1. Targeted concentration in specific organs/tissues.
  2. Safety with no allergic reactions or toxicity.
  3. Prepared under sterile conditions devoid of toxins or pyrogens.
  4. Radiochemical Purity: The proportion of radioactivity aligning with the defined chemical format of the preparation.
  5. Radionuclide Purity: The proportion of radioactivity tied to the declared radionuclide form.

Effective Half-Life of Radiopharmaceuticals

• Concepts:
  • Physical Half-Life (Tₚ): Time needed for radioactivity to diminish by 50%.
  • Biological Half-Life (T_b): Time required for the body to eliminate 50% of the compound through biological mechanisms.
  • Effective Half-Life (Tₑ): Combined time accounting for both physical and biological half-lives where the total radioactivity decreases by half.
  • The relationship is described as follows:
    rac{1}{Te} = rac{1}{Tp} + rac{1}{T_b}

Radiopharmaceutical Preparation and Administration

1. Preparation within a sterile lab environment.
2. Administering the radiopharmaceutical to the patient as appropriate for the diagnostic or therapeutic objective.

Physiological Studies Using Radiopharmaceuticals

• Applications: Comprise a range of diagnostic needs across numerous medical conditions such as:
  • Cancer treatment (oncology)
  • Brain imaging, stroke, and epilepsy diagnostics
  • Assessment for various organ functions (e.g., cardiac, renal).

Radiopharmaceutical Selection Criteria

• Ensure monitoring of distribution/concentration in biological systems
• High selectivity towards targeted tissues (>90%)
• Non-allergenic/non-toxic with sterile preparation to prevent contamination.

--

Properties of Radionuclides for Pharmaceutical Use

• Key Properties:
  1. Short physical half-life to limit prolonged radiation exposure while allowing sufficient study duration
  2. Low photon energy for minimal absorbed dose.
  3. Optimal photon emission energy suitable for imaging systems (e.g., NaI crystals).
  4. Safe and effective preparation; cost-effective for regular examinations.
  5. Gamma radiation only for imaging.

Mo-99/Tc-99m Generator: Functioning Basics

Structure

• The generator consists of a Molybdenum-99 (Mo-99) source secured on a column with protective shielding such as lead for safety.

Decay Process

• Mo-99 beta-decays into Technetium-99m (Tc-99m), a crucial short-lived radionuclide used in diagnostic imaging.
  • Extraction involves "milking" the generator, where a saline solution dissolves soluble TcO₄⁻ while retaining Mo-99 on the alumina column.

Applications of Tc-99m

• Extensively utilized in diverse imaging procedures for bone scans, cardiac imaging, and tumor detection among others.

Advantages of Tc-99m

• Attributes:
  • Short half-life (6 hours) results in lower radiation exposure to patients.
  • Emits only gamma radiation, minimizing damage to tissues
  • Suitable for a wide array of diagnostic applications due to its binding versatility.

Safe Handling Procedures

Protection Mechanisms During Syringe Filling and Administration

1. Lead shielding during preparation to protect against radiation exposure.
2. Controlled IV injections within shielded environments ensuring safety for patients and staff.

Understanding Radiopharmaceutical Creation

Components of a Radiopharmaceutical

• Radioactive Compound: Provide gamma emissions.
• Targeting Molecule: Customized to direct the radionuclide to specific tissues/organs.
• Linker: Ensures stable attachment of the components.

Imaging Process

• Patients receive radiopharmaceuticals via injections or oral ingestion, depending on the organ targeted.
• Gamma rays emitted from localized areas, primarily cancerous tissues, are then captured by imaging devices.

Radiopharmaceutical Categories

1. Cold Compounds: Leverage the attached compound's properties for imaging.
2. Autonomous Compounds: Depend on the radiopharmaceutical’s intrinsic properties (e.g., iodine-131 for thyroid applications).

Clinical Applications of Radiopharmaceuticals

• Examples include:\n - Iodine-131 Sodium: For hyperthyroidism and thyroid cancer treatment.
  • Phosphorus-32 Sodium: Used for polycythemia vera.
  • Strontium-89 Chloride: Alleviates pain in bone metastases.

Properties of Ideal Diagnostic Radiopharmaceuticals

Criteria:

• Clean photon emission to avoid contamination.
• Suitable energy range (100-250 keV) for optimal imaging.
• High target uptake ratio to enhance contrast.
• Minimal radiation exposure to ensure safety.
• Chemical stability and efficient cost and preparation processes.

Summary of Nuclear Medicine

• Focus on Functional Imaging: Operates leveraging biodistribution of tracers instead of merely anatomical paradigms.
• Key Components:
  • Radionuclide: Isotope emitting gamma rays.
  • Radiopharmaceutical: A combination of a radionuclide and a bioactive molecule.
  • Imaging Systems: Employed devices to ascertain emitted radiation for diagnosis.
• Advanced Applications: Utilize unique properties of radiopharmaceuticals for enhanced diagnostic capabilities and technological integration.

Imaging Diagnostic Systems - Gamma and PET Cameras

Gamma Camera

Basic Principles

• Main Function: Detects and images gamma radiation emitted by radioisotopes administered to the patient. The goal is to generate images reflecting organ functionality and physiology.

Gamma Camera Operation Steps

1. Administration of radiopharmaceutical containing a radioactive isotope (e.g., Tc-99m).
2. Emission of gamma radiation from the body as the isotope decays.
3. Detection by the scintillation crystal inside the gamma camera.
4. Conversion of light to signal via photomultiplier tubes.
5. Image Generation by processing the data.

PET Camera

Basic Principle

• Based on detecting gamma radiation from positron-electron annihilations, PET creates three-dimensional maps of organ functions within the body.

PET Camera Operation Steps

1. Administration of radiopharmaceuticals like FDG that emits positrons.
2. Positron collisions with tissue electrons cause annihilation, resulting in gamma photons.
3. Simultaneously capturing photons to identify radiation origin through timing and positional calculations.
4. Comprehensive image creation harnessing multiple emissions processed by computing systems.

Clinical Studies and Applications

Static and Dynamic Studies

Static Studies (e.g., Scintigraphy)

• Examples include:
  • Bone scans for skeletal issues
  • Lung imaging for perfusion and ventilation using Les-133 or Tc-99m.

Dynamic Studies

• Measurement of tissue functions over time (e.g., kidney studies determining perfusion and uptake).

Comprehensive Visualization Techniques

1. Thyroid Gland Study: Offers structural and functional insights into the gland including uptake percentages.
2. Dynamic Kidney Study: Determines perfusion, uptake, and excretion using sequential imaging.

Addressing Patient Clinical Cases

• Child Abuse Cases: Highlight example cases during diagnostic imaging contextualizing skeletal injuries using nuclear medicine imaging techniques.
• Myocardial Scintigraphy: Uses Thallium-201 to illustrate myocardial blood flow and cellular metabolism informing ischemic conditions.
• Brain Scintigraphy: Outlines diagnostic imaging potential for cognitive impairments and tumor identifications.

Conclusion

• Nuclear Medicine serves as a crucial fusion of medical imaging, radiopharmaceutical advancements, and clinical diagnostics to address a spectrum of medical conditions through innovative techniques, significantly enhancing patient care and treatment outcomes.